Leading Pharmaceutical Company Selects STARLIMS for $2.1 Million Global LIMS Project

HOLLYWOOD, Fla., Jan. 25, 2008 (PRIME NEWSWIRE) -- STARLIMS Technologies Ltd.
(Nasdaq:LIMS), a leading provider of laboratory information management systems
(LIMS), today announced that it has been selected by one of the world's leading
pharmaceutical companies for a $2.1 million LIMS project. STARLIMS v10 will be
implemented in the pharmaceutical company's Research and Development and Quality
Assurance laboratories in North America, Europe and Asia.

A LIMS for Global Synergy

"Being selected by one of the world's largest pharmaceutical companies is
clearly a vote of confidence in our vision of creating a single web-based
platform for laboratory informatics, covering multiple lab disciplines and
reaching across the globe," said Jeff Ferguson COO at STARLIMS. "We are seeing
more companies standardizing their LIMS solutions across the enterprise and we
believe STARLIMS v10 is well positioned to meet this demand."

Enhanced Collaboration across Disciplines and Continents

Implementing STARLIMS will facilitate the sharing of scientific data and best
practices across multiple laboratory sites. The pharmaceutical customer intends
to standardize on STARLIMS, beginning with eight sites. One of the key
considerations the customer had in selecting STARLIMS was its scalability, a
benefit of its entirely web-based architecture. In addition, STARLIMS offers
multilingual and multi-time zone support, important considerations for
distributed LIMS implementations.

Streamlined IT Requirements

By standardizing on STARLIMS, the company is expected to enhance regulatory
compliance and traceability, by facilitating more consistent reporting and
enhancing data security. The web based STARLIMS v10 system will simplify
deployment, validation, scale up and upgrade of the system while reducing
resource requirements for ongoing maintenance.

About STARLIMS

STARLIMS Technologies Ltd. (Nasdaq:LIMS) is a leading provider of laboratory
information management systems (LIMS), with over 20 years of LIMS experience.
The Company's flagship product, STARLIMS(r), improves the reliability of
laboratory sampling processes, supports compliance with domestic and
international regulations and industry standards, and provides comprehensive
reporting, monitoring and analysis capabilities. STARLIMS software is used for
quality assurance and control, testing and monitoring, and research and
development in government, manufacturing and life sciences organizations. With
operations in the United States, Canada, the United Kingdom, Israel and Hong
Kong, the company serves over 500 organizations in 40 countries. For more
information, please see http://www.starlims.com.

Safe Harbor for Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
involve known and unknown risks and uncertainties which could cause the actual
results, performance or achievements of the company to be materially different
from those which may be expressed or implied by such statements, including,
among others, changes in general economic and business conditions, changes in
demand for products and services, the timing and amount or cancellation of
orders, loss of market share and other risks detailed from time to time in
STARLIMS's filings from time to time with the Securities and Exchange
Commission. Such filings contain and identify these and other important factors
that could cause actual results to differ materially from those contained in our
projections or forward-looking statements. Shareholders and other readers are
cautioned not to place undue reliance on these forward-looking statements, which
speak only as of the date on which they are made. We undertake no obligation to
update publicly or revise any forward-looking statement.

-0-
CONTACT: STARLIMS Technologies Ltd.
Tamar Harris, Director of Corporate Communications
(604) 961-6121
tamar.harris@starlims.com

Integrated Corporate Relations (ICR)
Michael Kern, Investor Relations
(617) 956-6731
michael.kern@icrinc.com